There are a whole bunch of middle ground deals that CytoDyn could capitalize on like combination treatments with BP, which are all the rage in oncology and remember SK called us an oncology company. Leronlimab would reactivate the immune system to extend the anti-tumor response of some BP established drug with no side effects.